A recent study in which >500 lung adenocarcinoma cases were analyzed for possible contribution of BTK to an immune-dominant profile of the TME revealed that BTK expression in the TME was associated with a less aggressive disease and an improved survival outcome (Bi et al., 2020). Here, BTK is linked to lung adenocarcinoma.